| Polyamine immunometabolism: central regulators of inflammation, cancer and autoimmunity T Chia, A Zolp, J Miska Cells 11 (5), 896, 2022 | 29 | 2022 |
| Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth A Rashidi, LK Billingham, A Zolp, T Chia, C Silvers, JL Katz, CH Park, ... Cell Metabolism 36 (1), 62-77. e8, 2024 | 6 | 2024 |
| B-cells drive response to PD-1 blockade in glioblastoma upon neutralization of TGFβ-mediated immunosuppression D Hou, B Castro, M Dapash, A Zolp, J Katz, V Arrieta, J Biermann, ... Research Square, 2023 | 1 | 2023 |
| DDRE-34. RIBONUCLEOTIDE REDUCTASE REGULATORY SUBUNIT M2 AS A DRIVER OF GLIOBLASTOMA TMZ-RESISTANCE THROUGH MODULATION OF dNTP PRODUCTION E Perrault, J Shireman, P Lin, E Ali, A Zolp, S Budhiraja, C Park, ... Neuro-Oncology 23 (Supplement_6), vi81-vi82, 2021 | 1 | 2021 |
| CRISPR-Cas9 Screen Reveals PSMB3 Contributes to Gliomagenesis Through Proteasome-Dependent and Independent Mechanisms S Baisiwala, S Budhiraja, AJ Zolp, K Nandoliya, L Chen, CH Park, ... bioRxiv, 2021.07. 28.453566, 2021 | 1 | 2021 |
| TMET-14. TUMOR-ASSOCIATED MYELOID CELL-DERIVED CREATINE PROMOTES GLIOBLASTOMA GROWTH IN HYPOXIC NICHES AND PSEUDOPALISADING TUMOR REGIONS A Zolp, A Rashidi, TY Chia, C Dmello, V Arrieta, J Zhao, B Castro, ... Neuro-Oncology 24 (Suppl 7), vii264, 2022 | | 2022 |
| TMIC-42. LEVERAGING B CELL IMMUNITY TO PROMOTE IMMUNOTHERAPY IN GLIOBLASTOMA D Hou, B Castro, A Zolp, M Dapash, V Arrieta, J Zhao, P Zhang, A Rashidi, ... Neuro-Oncology 24 (Suppl 7), vii280, 2022 | | 2022 |
| MICROPERFUSION-MEDIATED SOLUBLE EXTRACELLULAR ENVIRONMENT ANALYSIS FOR DETERMINATION OF CHEMOTHERAPEUTIC EFFICACY IN BRAIN TUMORS I Olson, A Zolp, D Ventarapragada, J Miska, A Ahmed NEURO-ONCOLOGY 24, 6-6, 2022 | | 2022 |
| EXTH-52. HARNESSING AB CELL THERAPY TO PROMOTE ANTI-GLIOBLASTOMA HUMORAL RESPONSE B Castro, M Fischietti, A Zolp, J Zhao, D Hou, L Nguyen, H Wan, P Zhang, ... Neuro-Oncology 24 (Supplement_7), vii220-vii221, 2022 | | 2022 |
| 830 Targeting B cell suppression to improve the efficacy of immunotherapies in brain cancer D Hou, B Castro, A Zolp, M Dapash, V Arrieta, J Biermann, J Melms, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| OS08. 6. A Novel role of ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM S Budhiraja, S Baisiwala, E Perrault, S Cho, G Dara, K Nandoliya, A Zolp, ... Neuro-Oncology 24 (Suppl 2), ii19, 2022 | | 2022 |
| Identification of Targetable Glioblastoma Specific Antigens Using a B-cell-based Vaccine B Castro, M Dapash, D Hou, C Lee-Chang, M Lesniak, J Miska, L Nguyen, ... JOURNAL OF NEUROSURGERY 136 (5), 2022 | | 2022 |
| CBIO-13. THOC1 DRIVES GBM AGGRESSION THROUGH MODULATION OF R-LOOPS AND GENOMIC STABILITY S Budhiraja, S Baisiwala, K Nandoliya, L Chen, C Dmello, E Perrault, ... Neuro-Oncology 23 (Supplement_6), vi29-vi30, 2021 | | 2021 |
| DDRE-24. ARF4-MEDIATED RETROGRADE TRAFFICKING PROMOTES CHEMORESISTANCE IN GBM S Budhiraja, S Baisiwala, K Nandoliya, G Dara, E Perrault, A Zolp, L Chen, ... Neuro-Oncology 23 (Supplement_6), vi79-vi79, 2021 | | 2021 |
| STEM-16. TRYPTOPHANYL tRNA SYNTHETASE (trpRS) FUNCTIONS AS A PRO-STEMNESS CYTOKINE DURING CHEMOTHERAPY IN GLIOBLASTOMA K Nandoliya, S Budhiraja, J Shireman, A Zolp, P Lin, E Perrault, C Park, ... Neuro-Oncology 23 (Suppl 6), vi24, 2021 | | 2021 |
| ARF4-mediated Retrograde Trafficking Drives Chemoresistance in Glioblastoma S Budhiraja, S Baisiwala, E Perrault, S Cho, K Nandoliya, G Dara, A Zolp, ... bioRxiv, 2021.07. 18.451328, 2021 | | 2021 |
| Using whole-genome CRISPR-Cas9 screening to identify resistance networks in glioblastoma S Budhiraja, S Baisiwala, E Perrault, L Chen, C Park, C Awah, C Dmello, ... Cancer Research 81 (13_Supplement), 1328-1328, 2021 | | 2021 |
